Adam Thomas

Emerg Doc / Intensivist. FOAMite. Podcast host for @iBookCC. Passionate about medical education & innovation

[Adam Thomas @adamdavidthomas]

And with that, @iBookCC just posted our 100th episode. Thanks for everyone's continued support! @PulmCrit

[Adam Thomas @adamdavidthomas]

@TheSGEM @MelHerbert @emrap_tweets The medicine is on point. And this 15 hour shift would be a dream! (Medical case wise).

[Tommaso Scquizzato, MD @tscquizzato]

2 RCTs testing IV vs IO vascular access in OHCA patients just published in the @NEJM and concomitantly presented at #RESUS24 @ERC_resus

➡️ No difference in 30d survival in both trials
➡️ Higher rate of ROSC with IV access in the #PARAMEDIC3 trial

🇬🇧 https://t.co/fXpWqcVfRT
🇩🇰 https://t.co/FFZYVTXkFl

Congratulations to the authors for randomizing 6082 + 1506 patients to answer this important question!

[Paul Wischmeyer MD @Paul_Wischmeyer]

🚨 🏥 Please Retweet! Early enteral #nutrition (EN) w/in 3 d of ICU admit/intubation improves outcomes!

⬇️ Hospital MORTALITY
⬆️ D/C to Home
⬇️ ICU & Hosp LOS
⬇️ Vent Days
⬇️ Costs

🙋‍♂️Data from >27800 pts in real world practice
🔗 https://t.co/EdZuzRIg17
#ICUNutrition #FOAMcc
@drsh@drshahrul80 @ICUnutrition

[Josh Farkas MD 💊 @PulmCrit]

Hot Take on PROPHY-VAP trial:

🔥Prophylactic 2g ceftriaxone among patients intubated for airway protection reduced pneumonia & ICU/hospital length of stay

🔥Prophylaxis *reduced* total antibiotic exposure

🔥Consistent w/ SuDDICU & ANTHARTIC trials

Blog https://t.co/lXF1jMyj6a

[小谷祐樹 Yuki Kotani｜集中治療医 @YukiKotani5]

Single-dose cefreiaxone to prevent VAP in ventilated acute brain injury patients

Multicenter RCT with 345 pts🇫🇷

Compared to placebo, CTRX reduced VAP (14% vs 32%; HR 0·60 [0·38–0·95], p=0·03)

https://t.co/pWGkfLuP7a
@SCCM @KhannaAshishCCM @SCCMPresident #SCCM2024

[Elliot Tapper @ebtapper]

The liver is awesome.

Yet its vocabulary is ... limited.

We can all tell when it is upset - high ALT, AST.

But that could mean anything!

So what's your specific patient's specific reason for high ALT?

[Elliot Tapper @ebtapper]

True story

There have been 15 trials of tooth brushing in the ICU

and those trials have demonstrated fewer pneumonias and icu deaths

In @JAMAInternalMed

https://t.co/OisrG9d1Sj

[Abdulla A. Damluji, MD, PhD @DrDamluji]

Great #AHA23 so far: @AHA_Research

🥸8 Trials: 8 take aways below

Read the read👇👇

1/ATRESIA:

Patients with subclinical atrial fibrillation can benefit from apixaban to reduce the risk of stroke and systemic thromboembolism.

[Josh Farkas MD 💊 @PulmCrit]

New IDSA/SCCM guidelines on evaluation of new fever in ICU!

🤒 bladder/esophageal > rectal > oral > axillary/ear

🤒CRP and/or procal rec for patients with low/intermediate risk of infection😳

🤒consider test for COVID, resp viruses

Fresh blogitorial: https://t.co/vgILWsi9E3

[Adam Thomas @adamdavidthomas]

@khaycock2 @ross_prager @karimbrohi @drjenwolkin @ThinkingCC @srrezaie @emcrit @adampowermd @dan___kim @UAlberta_Sono @WhatsUp_Doc123 @traumaicurounds I’m torn. Usually my priorities as TTL would be focused elsewhere or limited by space/people/time. But I have seen TEE change my management and optimize compressions etc. so for a narrow set of patients I think so. Reassured that right patient/exp provider no injuries caused!

[Deborah Siegal @DebSiegal]

STRATUS Trial published @JAMA_current
🩸Cluster trial 25 ICUs >27,000 patients
🩸Switch to “small-volume” tubes that⬇️blood drawn for lab tests may⬇️RBC transfusion↔️effect on testing
🩸Available, cost-neutral, compatible with analyzers – will you switch?
https://t.co/sTkJVyfrgS

[Josh Farkas MD 💊 @PulmCrit]

fresh blog: why the new brain death guidelines are unacceptable

🧠guidelines rec urine tox screen & time-based clearance of intoxicants, *ignoring* toxicology guidelines & toxicologists

🧠arbitrary ranges are required for labs (iCal must be 1 -1.3 mM😳)

https://t.co/BxZcupmRuD

[Karim Brohi @karimbrohi]

OK here's a run down of why @CRYOSTAT_2 trial results will mark a turning point in the treatment of trauma-induced coagulopathy (TIC)

Paper in @JAMA_current: https://t.co/U9Yv0857JO

and some additional resources on our @CommsC4TS web pages: https://t.co/27fgr0DbfC

Firstly...

[James Horowitz @jameshorowitzmd]

Thanks to @accpchest for the opportunity to present high risk #PE data from #FLAME 🔥 at #CHEST2023!

(Finally have a good reason to use that emoji!)

FT pts w significant decreased primary outcome and in-hospital mortality (1/3)

@RosovskyRachel @roblookstein

[Adam Thomas @adamdavidthomas]

@HumanFact0rz

[Anton Helman @EMCases]

Very excited to have the voice and brains behind IBCC podcast and Crackcast, @adamdavidthomas co-instruct this year's Podcast CAMP Nov 30th, Dec 7th, Dec 14th. Plus keynote speaker @srrezaie of REBELCast
Details @ https://t.co/pVjmXYpdfs

[Josh Farkas MD 💊 @PulmCrit]

in case you use an RSS feed:

the new IBCC chapters will be going up on a *separate* IBCC RSS feed. to subscribe, click the link shown below & copy the text that shows up into your RSS reader.

and if you've achieved this peak level of nerdiness, I honestly salute you 🫡

[Adam Thomas @adamdavidthomas]

@boondocksdoc @PulmCrit Truth. I do!

[Adam Thomas @adamdavidthomas]

@docib @codachange @OliFlower @EMManchester @_NMay @precordialthump @HumanFact0rz @emcrit @stemlyns Just putting this out there… but can you all put the band together again? With #medtwitter dying I think we need to get back to the roots that started all of this. I’ll even commit to getting @PulmCrit on a flight for it!

[The Lancet @TheLancet]

#Opioid pain relievers do not reduce acute lower back and neck pain, new study suggests: https://t.co/rrc2ZYT6zY